Successful rescue of refractory acute antibody‐mediated renal allograft rejection with splenectomy – A case report
暂无分享,去创建一个
[1] D. Segev,et al. The Utility of Splenectomy as Rescue Treatment for Severe Acute Antibody Mediated Rejection , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] L. Rostaing,et al. Rituximab therapy for acute humoral rejection after kidney transplantation. , 2007, Transplantation.
[3] R. Montgomery,et al. Consensus Opinion from the Antibody Working Group on the Diagnosis, Reporting, and Risk Assessment for Antibody-Mediated Rejection and Desensitization Protocols , 2004, Transplantation.
[4] S. Jordan,et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. , 2008, The New England journal of medicine.
[5] Wu Jianyong,et al. C4d as a significant predictor for humoral rejection in renal allografts , 2005, Clinical transplantation.
[6] E. Benedetti,et al. Successful Rescue of Refractory, Severe Antibody Mediated Rejection with Splenectomy , 2007, Transplantation.
[7] D. Segev,et al. The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody‐Mediated Rejection , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] R. Gruessner,et al. Histopathology and Immunophenotype of the Spleen During Acute Antibody‐Mediated Rejection , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] K. Kokko,et al. Transplanting the Highly Sensitized Patient: The Emory Algorithm , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] D. Nochy,et al. Determinants of Poor Graft Outcome in Patients with Antibody‐Mediated Acute Rejection , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] M. Haas,et al. Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients , 2010, Transplantation.
[12] V. Sánchez. Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation , 2010 .
[13] J. Tuttle-Newhall,et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection1 , 2003, Transplantation.
[14] Francis L. Delmonico,et al. ACUTE HUMORAL REJECTION IN RENAL ALLOGRAFT RECIPIENTS: I. INCIDENCE, SEROLOGY AND CLINICAL CHARACTERISTICS1 , 2001, Transplantation.
[15] R. Colvin,et al. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. , 1998, Transplantation.
[16] R. Colvin,et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. , 2002, Journal of the American Society of Nephrology : JASN.
[17] M. Pascual,et al. New treatments for acute humoral rejection of kidney allografts , 2007, Expert opinion on investigational drugs.
[18] G. Einecked,et al. Banff 07 Classification of Renal Allograft Pathology : Updates and Future Directions , 2008 .